Loading company details...
Latest Form 4 (May 18, 2026): Kristen Yen (Officer title: SVP Global Clinical Operations and Patient Advocacy): Disposition to Issuer of 37,639 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| May 18, 2026 | Kristen Yen, Officer title: SVP Global Clinical Operations and Patient Advocacy | Disposition to Issuer | 37,639 | n/a |
| May 18, 2026 | Birgitte Volck | Disposition to Issuer | 17,536 | n/a |
| May 18, 2026 | Andrew Sinclair | Disposition to Issuer | 10,491 | n/a |
| May 18, 2026 | Matthew Pauls | Disposition to Issuer | 10,491 | n/a |
| May 18, 2026 | Kevin Norrett, Chief Business Officer | Disposition to Issuer | 17,786 | n/a |
| May 18, 2026 | Meredith Manning, Chief Commercial Officer | Disposition to Issuer | 64,507 | n/a |
| May 18, 2026 | Manher Joshi, Chief Development Officer | Disposition to Issuer | 20,171 | n/a |
| May 18, 2026 | Michael F. Huang, Sr. VP of Clinical Development | Disposition to Issuer | 39,823 | n/a |
| May 18, 2026 | Patricia C. Hirano, Officer title: Senior Vice President, Regulatory Affairs | Disposition to Issuer | 22,702 | n/a |
| May 18, 2026 | Mark W. Hahn | Disposition to Issuer | 10,046 | n/a |